1.
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-c...
by Anthenelli, Robert M, Prof
The Lancet (British edition), 2016, Vol.387 (10037), p.2507-2520
2.
Electronic cigarettes for smoking cessation: a randomised controlled trial
by Bullen, Christopher, Dr
The Lancet (British edition), 2013, Vol.382 (9905), p.1629-1637
3.
Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades?
by Zhu, Shu-Hong
Tobacco Control, 2012-03, Vol.21 (2), p.110-118
4.
Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial
by Free, Caroline, Dr
The Lancet (British edition), 2011, Vol.378 (9785), p.49-55
5.
Tobacco taxes as a tobacco control strategy
by Chaloupka, Frank J
Tobacco control, 2012-03, Vol.21 (2), p.172-180
6.
Impact of graphic and text warnings on cigarette packs: findings from four countries over five years
by Borland, R
Tobacco control, 2009-10, Vol.18 (5), p.358-364
7.
The Effect of the COVID-19 Pandemic on Smoking Cessation Success
by Kayhan Tetik, Burcu
Journal of community health, 2020-07-08, Vol.46 (3), p.471-475
8.
Cardiovascular Toxicity of Nicotine: Implications for Electronic Cigarette Use
by Benowitz, Neal L
Trends in cardiovascular medicine, 2016, Vol.26 (6), p.515-523
9.
Varenicline decreases alcohol consumption in heavy-drinking smokers
by Mitchell, Jennifer M
Psychopharmacologia, 2012-05-01, Vol.223 (3), p.299-306
10.
Pictorial cigarette pack warnings: a meta-analysis of experimental studies
by Noar, Seth M Seth M
Tobacco control, 2015-05-06, Vol.25 (3), p.341-354
11.
Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial
by Bullen, C
Tobacco control, 2010-04, Vol.19 (2), p.98-103
12.
13.
Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch–Belgian randomised controlled lung cancer screening trial
by van der Aalst, Carlijn Michelle
Thorax, 2010-07, Vol.65 (7), p.600-605
14.
Smoking Among HIV Positive New Yorkers: Prevalence, Frequency, and Opportunities for Cessation
by Tesoriero, James M
AIDS and behavior, 2008-09-07, Vol.14 (4), p.824-835
15.
New Methods for Tobacco Dependence Treatment Research
by Baker, Timothy B
Annals of behavioral medicine, 2010-12-03, Vol.41 (2), p.192-207
16.
Association between use of nicotine replacement therapy for harm reduction and smoking cessation: a prospective study of English smokers
by Beard, Emma
Tobacco control, 2013-03, Vol.22 (2), p.118-122
17.
Common predictors of smoking cessation in clinical practice
by Caponnetto, Pasquale
Respiratory medicine, 2008, Vol.102 (8), p.1182-1192
18.
Markers of the denormalisation of smoking and the tobacco industry
by Chapman, S
Tobacco Control, 2008-02, Vol.17 (1), p.25-4
19.
Explaining the social gradient in smoking cessation: it’s not in the trying, but in the succeeding
by Kotz, D
Tobacco control, 2009-02, Vol.18 (1), p.43-46
20.
Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors
by Powell, Jane
Psychopharmacologia, 2010-12, Vol.212 (4), p.537-549
